GSK Divests China Suzhou Site, Antiviral Rights To Fosun

 
• By Brian Yang
  
China - Suzhou City
GSK DIVESTS SUZHOU PRODUCTION SITE AND LAMIVUDINE RIGHTS TO FOSUN • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia